These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 12878699)

  • 1. Abnormal dysbindin expression in cerebellar mossy fiber synapses in the mdx mouse model of Duchenne muscular dystrophy.
    Sillitoe RV; Benson MA; Blake DJ; Hawkes R
    J Neurosci; 2003 Jul; 23(16):6576-85. PubMed ID: 12878699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dysbindin, a novel coiled-coil-containing protein that interacts with the dystrobrevins in muscle and brain.
    Benson MA; Newey SE; Martin-Rendon E; Hawkes R; Blake DJ
    J Biol Chem; 2001 Jun; 276(26):24232-41. PubMed ID: 11316798
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Stay TL; Miterko LN; Arancillo M; Lin T; Sillitoe RV
    Dis Model Mech; 2019 Dec; 13(2):. PubMed ID: 31704708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms and Consequences of Cerebellar Purkinje Cell Disinhibition in a Mouse Model of Duchenne Muscular Dystrophy.
    Wu WC; Bradley SP; Christie JM; Pugh JR
    J Neurosci; 2022 Mar; 42(10):2103-2115. PubMed ID: 35064002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel somatostatin-immunoreactive mossy fiber pathway associated with HSP25-immunoreactive purkinje cell stripes in the mouse cerebellum.
    Armstrong CL; Chung SH; Armstrong JN; Hochgeschwender U; Jeong YG; Hawkes R
    J Comp Neurol; 2009 Dec; 517(4):524-38. PubMed ID: 19795496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebellar synaptic defects and abnormal motor behavior in mice lacking alpha- and beta-dystrobrevin.
    Grady RM; Wozniak DF; Ohlemiller KK; Sanes JR
    J Neurosci; 2006 Mar; 26(11):2841-51. PubMed ID: 16540561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced postsynaptic GABAA receptor number and enhanced gaboxadol induced change in holding currents in Purkinje cells of the dystrophin-deficient mdx mouse.
    Kueh SL; Dempster J; Head SI; Morley JW
    Neurobiol Dis; 2011 Sep; 43(3):558-64. PubMed ID: 21601636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of protein inhibitor of neuronal nitric oxide synthase in Duchenne muscular dystrophy.
    Guo Y; Petrof BJ; Hussain SN
    Muscle Nerve; 2001 Nov; 24(11):1468-75. PubMed ID: 11745948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinvestigation of the dysbindin subunit of BLOC-1 (biogenesis of lysosome-related organelles complex-1) as a dystrobrevin-binding protein.
    Nazarian R; Starcevic M; Spencer MJ; Dell'Angelica EC
    Biochem J; 2006 May; 395(3):587-98. PubMed ID: 16448387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term depression is reduced in cerebellar Purkinje cells of dystrophin-deficient mdx mice.
    Anderson JL; Head SI; Morley JW
    Brain Res; 2004 Sep; 1019(1-2):289-92. PubMed ID: 15306266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of a NOS transgene in dystrophin-deficient muscle reduces muscle membrane damage without increasing the expression of membrane-associated cytoskeletal proteins.
    Tidball JG; Wehling-Henricks M
    Mol Genet Metab; 2004 Aug; 82(4):312-20. PubMed ID: 15308129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional and genotypic differences in intrinsic electrophysiological properties of cerebellar Purkinje neurons from wild-type and dystrophin-deficient mdx mice.
    Snow WM; Anderson JE; Fry M
    Neurobiol Learn Mem; 2014 Jan; 107():19-31. PubMed ID: 24220092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein-Anchoring Therapy of Biglycan for Mdx Mouse Model of Duchenne Muscular Dystrophy.
    Ito M; Ehara Y; Li J; Inada K; Ohno K
    Hum Gene Ther; 2017 May; 28(5):428-436. PubMed ID: 27485975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of (-)-epicatechin on frontal cortex DAPC and dysbindin of the mdx mice.
    Estrada-Mena FJ; Rodriguez A; Mendoza-Lorenzo P; Neri-Gomez T; Manjarrez-Gutierrez G; Perez-Ortiz AC; Ordonez-Razo R; Ceballos G; Villarreal F; Ramirez-Sanchez I
    Neurosci Lett; 2017 Sep; 658():142-149. PubMed ID: 28855126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy.
    Bia BL; Cassidy PJ; Young ME; Rafael JA; Leighton B; Davies KE; Radda GK; Clarke K
    J Mol Cell Cardiol; 1999 Oct; 31(10):1857-62. PubMed ID: 10525423
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain function in Duchenne muscular dystrophy.
    Anderson JL; Head SI; Rae C; Morley JW
    Brain; 2002 Jan; 125(Pt 1):4-13. PubMed ID: 11834588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Syntrophins and dystrobrevins: defining the dystrophin scaffold at synapses.
    Albrecht DE; Froehner SC
    Neurosignals; 2002; 11(3):123-9. PubMed ID: 12138249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced expression of the alpha 7 beta 1 integrin reduces muscular dystrophy and restores viability in dystrophic mice.
    Burkin DJ; Wallace GQ; Nicol KJ; Kaufman DJ; Kaufman SJ
    J Cell Biol; 2001 Mar; 152(6):1207-18. PubMed ID: 11257121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purkinje cell neuroaxonal dystrophy similar to nervous mutant mice phenotype in two sibling kittens.
    Résibois A; Poncelet L
    Acta Neuropathol; 2004 Jun; 107(6):553-8. PubMed ID: 15042386
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal kainic acid receptor density and reduced seizure susceptibility in dystrophin-deficient mdx mice.
    Yoshihara Y; Onodera H; Iinuma K; itoyama Y
    Neuroscience; 2003; 117(2):391-5. PubMed ID: 12614679
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.